Format

Send to

Choose Destination
J Thorac Oncol. 2018 Jun;13(6):767-778. doi: 10.1016/j.jtho.2018.04.002. Epub 2018 Apr 12.

Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017.

Author information

1
Department of Cardiothoracic Surgery, New York University Medical Center, New York, New York. Electronic address: Jessica.donington@nyumc.org.
2
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea.
3
Division of Cardiovascular and Thoracic Surgery, Duke University School of Medicine, Durham, North Carolina.
4
Department of Pathology, New York University Medical Center, New York, New York.
5
Division of Pulmonary Medicine, New York University Medical Center, New York, New York.
6
Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
7
Division of Thoracic Surgery, Mayo Clinic, Rochester, Minnesota.
8
Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
9
Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, California.
10
Department of Surgery, Yale University, New Haven, Connecticut.
11
Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California.
12
Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
13
Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem, Belgium.

Abstract

The landscape of care for early-stage non-small cell lung cancer continues to evolve. While some of the developments do not seem as dramatic as what has occurred in advanced disease in recent years, there is a continuous improvement in our ability to diagnose disease earlier and more accurately. We have an increased understanding of the diversity of early-stage disease and how to better tailor treatments to make them more tolerable without impacting efficacy. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in the care of early-stage lung cancer patients have provided focused updates across multiple areas including screening, pathology, staging, surgical techniques and novel technologies, adjuvant therapy, radiotherapy, surveillance, disparities, and quality of life. The source for information includes large academic meetings, the published literature, or novel unpublished data from other international oncology assemblies.

KEYWORDS:

Adjuvant therapy; Intraoperative lymph node evaluation; Non–small cell lung cancer; Pathology; Radiotherapy; Screening; Sublobar resection; Surgery; Surveillance

PMID:
29654928
DOI:
10.1016/j.jtho.2018.04.002
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center